is the semaglutide shortage over Injections and FDA The Ozempic Shortage Is Over

All analyses are based on 95% confidence intervals

GLP-1 patches are skin-based treatments that promise the same results as injectable GLP-1s without needles and at a lower price

Most doctors recommend an average A1c of 7 or less

Furthermore, increased healthcare expenditure, demand for innovative therapies, growing awareness for early detection and diagnosis, supportive government initiatives and regulatory frameworks, access to expert healthcare professionals and, the proven efficacy and safety of GLP-1 receptor agonists for managing blood sugar and promoting weight loss are the factors fuelling the market dominance of this segment